COVID-19 Supplement Approvals Jump, Some On-Time Decision Rates Slip For US FDA

 
• By Derrick Gingery
On-Time flight board
The FDA made all biosimilar application decisions on time during the third quarter of FY 2021. • Source: Alamy

More from Product Reviews

More from Pink Sheet